As of Apr 24
| -0.0734 / -2.20%|
The 3 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +114.51% increase from the last price of 3.26.
The current consensus among 4 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.